Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study. [electronic resource]
Producer: 20200610Description: 2246-2256 p. digitalISSN:- 1527-7755
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Disease-Free Survival
- Etoposide -- administration & dosage
- Female
- Gene Rearrangement
- Germ-Line Mutation
- Histone-Lysine N-Methyltransferase -- genetics
- Humans
- Infant
- Infant, Newborn
- Male
- Mercaptopurine -- administration & dosage
- Mitoxantrone -- administration & dosage
- Myeloid-Lymphoid Leukemia Protein -- genetics
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.